课题基金 / 基金详情

miR-128靶向GAREM调控ERK/MAPK信号通路影响牦牛子宫内膜炎症损伤的分子机制

批准号:
32060820
项目类别:
地区科学基金项目
资助金额:
35.0 万元
负责人:
董海龙
依托单位:
学科分类:
临床兽医学
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
董海龙

项目摘要

结项摘要

相似基金

相关文献

中文摘要
子宫内膜炎是影响牦牛产业发展的重要疾病之一。我们前期研究发现:MAPKs信号通路关键因子在牦牛子宫内膜炎症损伤过程中存在差异性表达;同时,我们通过荧光定量RT-PCR证实miR-128及其靶基因GAREM在牦牛子宫内膜炎症损伤过程中表达异常。那么牦牛子宫内膜炎发病过程中,miR-128是否靶向GAREM调控ERK/MAPK信号通路影响炎症的发生?机制是什么?目前尚无报道。为此,本项目拟以牦牛子宫内膜上皮细胞为模型,通过miR-128及其靶基因GAREM过表达或干扰、荧光定量RT-PCR及Western blot等方法,研究miR-128及GAREM表达对LPS诱导牦牛子宫内膜炎症损伤的影响,以及miR-128在ERK/MAPK信号通路中所发挥的调控作用,阐明miR-128通过靶向GAREM调控ERK/MAPK信号通路影响牦牛子宫内膜炎症损伤的分子机制,为寻找相关治疗靶点提供理论依据。
英文摘要
Endometritis is one of the common postpartum disease in yaks, which seriously affects the reproductive performance. Our previous study found that the key factors of MAPKs signaling pathway are differently expressed in LPS induced inflammatory injury endometrium in Yaks; Meanwhile, we confirmed the abnormal expression of miR-128 and its target gene GAREM in LPS induced endometritis in Yaks by qRT-PCR. However, does miR-128 on endometritis in Yaks can target GAREM to regulate ERK/MAPK signaling pathway is still unknown, and what is the molecular mechanism? The relevant regulatory mechanism is still unclear. For these purpose, the endometrial epithelial cells from Yaks were cultured, and overexpression or silencing of miR-128 and GAREM, qRT-PCR and western blot were used to investigate the effects of miR-128 and GAREM expression, and regulatory role of miR-128 in ERK/MAPK signaling pathway on LPS-induced endometrial inflammatory injury in yaks. To further elucidate the molecular mechanism of miR-128 on inflammatory injury of LPS induced endometritis by targeting GAREM mediated ERK/MAPK signaling pathway, which will provide a theoretical basis for further revealing the therapeutic targets of endometritis in Yaks.
牦牛养殖业作为西藏经济支柱产业,长期受牦牛子宫内膜炎的严重威胁。该疾病导致牦牛流产、不孕等问题,造成重大经济损失。当前临床依赖抗生素治疗引发的耐药性问题亟待解决。基于miRNAs在炎症调控中的重要作用,本研究聚焦miR-128在牦牛子宫内膜炎中的分子机制,旨在为新型治疗策略提供理论依据。.本研究通过Western Blot、RT-qPCR技术检测临床样本与LPS诱导细胞模型中miR-128表达特征,结合生物信息学预测与双荧光素酶报告系统验证靶基因。采用基因过表达/干扰技术探究miR-128-GAREM调控网络,并通过MAPK信号通路特异性抑制剂阐明其作用机制。结果显示:1、临床样本与LPS细胞模型均显示:子宫内膜炎组织中miR-128表达显著低于健康对照组(P<0.01);2、miR-128过表达可使LPS模型MAPK通路蛋白(ERK/JNK/p38)及炎症因子(TNF-α、IL-6、IL-1β)表达量下降显著下降(P<0.01),miR-128过表达和沉默对损伤无显著影响;3、靶向验证确认GAREM为miR-128直接作用靶标,二者呈显著负调控;4、抑制GAREM的表达可使LPS模型MAPK通路蛋白(ERK/JNK/p38)及炎症因子(TNF-α、IL-6、IL-1β)表达量下降显著下降(P<0.01),GAREM过表达和沉默对损伤无显著影响;5、阻断JNK和p38通路后,miR-128过表达依然可使炎症因子表达量明显下降(P<0.05),表明miR-128通过ERK/MAPK信号通路进行调节;6、双基因共转染实验表明:miR-128靶向GAREM调节LPS诱导的牦牛子宫内膜炎;综上所述,miR-128通过靶向GAREM调控ERK/MAPK信号通路影响牦牛子宫内膜炎症。.本研究阐明了miR-128通过靶向GAREM调控ERK/MAPK信号通路介导牦牛子宫内膜炎的分子机制,为开发基于miRNA调控的精准治疗技术提供新靶点;对减少抗生素滥用、提升牦牛繁殖效率具有重要实践意义,为后续开发非抗生素类生物制剂奠定了理论基础,对保障青藏高原畜牧经济可持续发展具有重要科学价值。
国内基金
海外基金